Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Recent onset disequilibrium mimicking acute vestibulopathy in early multiple sclerosis.
Nutrients, Microglia Aging, and Brain Aging.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
Pregnancy in multiple sclerosis.
Costs and quality of life in multiple sclerosis patients with spasticity.
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis.
Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
MS patients must have access to the best treatment options.
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
Erratum: microRNA dysregulation in multiple sclerosis.
Clinical prospective study of visual function in patients with acute optic neuritis.
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »